What is the current Micro-RNA Sequencing and Assay market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Micro-RNA Sequencing and Assay market?

Increasing demand for genetic research and rising awareness of micro-RNA's role in disease diagnosis.

What are the major challenges facing the market?

High costs of sequencing and data analysis, and regulatory hurdles in clinical applications.

Which regions are leading the Micro-RNA Sequencing and Assay market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the Micro-RNA Sequencing and Assay market?

Illumina, Thermo Fisher, and Qiagen are among the top players in the market.

What are the future opportunities in the Micro-RNA Sequencing and Assay market?

Personalized medicine and non-invasive diagnostics are expected to drive future growth.

How does technology impact the Micro-RNA Sequencing and Assay market?

Advances in sequencing technologies and bioinformatics are increasing efficiency and accuracy.

What is the current regulatory landscape for the Micro-RNA Sequencing and Assay market?

Regulatory frameworks are evolving to address clinical validation and reimbursement issues.

What is the future outlook for the Micro-RNA Sequencing and Assay market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Micro-RNA Sequencing and Assay Growth Analysis & Future Outlook 2033

Micro-RNA Sequencing and Assay by Type (/> Sequencing by Synthesis, Sequencing by Nanopore, Ion Semiconductor Sequencing), by Application (/> Research Institute, Academia, CRO), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Micro-RNA Sequencing and Assay Market Size | CAGR 10.2 Forecast 2033

Micro-RNA Sequencing and Assay Growth Analysis & Future Outlook 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Micro-RNA Sequencing and Assay Market Overview

The Micro-RNA Sequencing and Assay market refers to the industry involved in the development and application of micro-RNA sequencing and assay technologies. As a crucial segment of the life sciences industry, the Micro-RNA Sequencing and Assay market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 13.5% during the forecast period from 2026 to 2033. This industry expansion is driven by factors such as increasing research and development activities in the field of micro-RNAs, rising demand for personalized medicine, and advancements in sequencing technologies. The scope of this market encompasses various types of micro-RNA sequencing and assay technologies, including quantitative real-time PCR, microarray, and next-generation sequencing, which are applied in different fields such as cancer research, neurological disorders, and cardiovascular diseases.

Loading chart…

The key forces shaping the Micro-RNA Sequencing and Assay industry include technology shifts towards more advanced and cost-effective sequencing technologies, regulatory developments that support the use of micro-RNAs in diagnostic and therapeutic applications, and changing consumer behavior towards personalized medicine. The largest region in the Micro-RNA Sequencing and Assay market is North America, driven by the presence of major research institutions and pharmaceutical companies. The fastest-growing region is expected to be the Asia-Pacific, driven by increasing investments in life sciences research and development. Overall, the Micro-RNA Sequencing and Assay market is expected to experience significant growth in the coming years, driven by its potential to revolutionize the field of medicine and improve human health.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; QIAGEN; Takara Bio; NEB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Micro-RNA Sequencing and Assay market is poised for significant growth, driven by various factors. Key growth drivers include:

Growth Drivers2 items

Increasing adoption of micro-RNA sequencing technologies in research and diagnostic applications, driving the Micro-RNA Sequencing and Assay market size

Advances in high-throughput sequencing technologies, enabling faster and more accurate analysis of micro-RNAs and contributing to the growth forecast

However, the market also faces certain restraints that may hinder its growth. Key restraints include:

Restraints2 items

High costs associated with micro-RNA sequencing and assay technologies, limiting accessibility for smaller research institutions and contributing to a slower growth forecast

Complexity of data analysis and interpretation, requiring specialized expertise and bioinformatics tools, which can be a barrier to entry for new market players

The Micro-RNA Sequencing and Assay market also presents several opportunities for growth and expansion. Key opportunities include:

Opportunities2 items

Growing demand for personalized medicine and targeted therapies, driving the need for micro-RNA sequencing and assay technologies and contributing to the Micro-RNA Sequencing and Assay market size

Increasing focus on cancer research and diagnosis, where micro-RNAs play a crucial role, and presenting opportunities for market players to develop innovative solutions

Despite these opportunities, the market also faces certain challenges that need to be addressed. Key challenges include:

Challenges2 items

Stringent regulatory requirements and standards for micro-RNA sequencing and assay technologies, which can be time-consuming and costly to comply with, affecting the growth forecast

Need for standardization of micro-RNA sequencing and assay protocols, to ensure consistency and comparability of results across different studies and applications

Market Segmentation

Loading chart…

The Micro-RNA Sequencing and Assay market can be segmented based on Type, which includes subtypes such as Micro-RNA Sequencing and Micro-RNA Assay. This segmentation contributes to the overall market size by providing a clear understanding of the different technologies used in the field. The Micro-RNA Sequencing segment involves the use of high-throughput sequencing technologies to analyze micro-RNA expression, while the Micro-RNA Assay segment involves the use of various assays to detect and quantify micro-RNA levels. Understanding the Micro-RNA Sequencing and Assay segmentation is crucial for industry players to develop targeted strategies and products.

The market can also be segmented based on Application, which includes subtypes such as Cancer Research, Neurological Disorders, and Infectious Diseases. This segmentation is critical in understanding the demand for micro-RNA sequencing and assay products in different disease areas. The Cancer Research segment is a significant contributor to the market, as micro-RNAs play a crucial role in cancer diagnosis and treatment. The market taxonomy of micro-RNA sequencing and assay products is complex, and understanding the application-based segmentation is essential for companies to develop products that cater to specific disease areas.

Micro-RNA Sequencing and Assay Segmentation Breakdown8 items

Type

/> Sequencing by Synthesis

Sequencing by Nanopore

Ion Semiconductor Sequencing

Application

/> Research Institute

Academia

CRO

Regional Insights

Loading chart…

The Micro-RNA Sequencing and Assay market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption rates, government investments in research and development, and a mature ecosystem.

The Asia Pacific region is the fastest-growing, driven by increasing demand for diagnostic services, expanding infrastructure, and rising investments in biotechnology. Europe is also a significant region, with key drivers including favorable policies, growing demographics, and established research institutions.

Latin America and Middle East & Africa are also expected to contribute to the Micro-RNA Sequencing and Assay market growth, with key drivers such as growing awareness, improving infrastructure, and increasing adoption rates. The regional forecast indicates a positive outlook for the market, with each region playing a crucial role in the overall growth.

Competitive Landscape

The Micro-RNA Sequencing and Assay market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Micro-RNA Sequencing and Assay competitive landscape is characterized by high competition, with key players employing diverse strategies to maintain their market position. Global players dominate the market, but local companies are also gaining traction, particularly in regional markets.

Companies in this market are adopting various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies are employing distinct strategies to compete in the market:

Illumina: regional expansion

Thermo Fisher Scientific: premium pricing

QIAGEN: innovation pipeline

Takara Bio: OEM tie-ups

NEB: local manufacturing

NEB: vertical integration

Key Micro-RNA Sequencing and Assay Companies5 items

Illumina

Thermo Fisher Scientific

QIAGEN

Takara Bio

NEB

Market Ecosystem

The Micro-RNA Sequencing and Assay ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development and deployment of sequencing and assay technologies, where technology providers supply critical components, and integrators assemble these into cohesive solutions for end users. The ecosystem's boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with various participants influencing the value chain analysis.

Technology providers — develop sequencing and assay technologies

Raw material/component suppliers — provide critical components and reagents

System integrators / EPCs — assemble and integrate sequencing and assay systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — utilize sequencing and assay technologies for research and diagnostics

Regulators/standards bodies — establish guidelines and standards for sequencing and assay technologies

The flow of value within the Micro-RNA Sequencing and Assay ecosystem is influenced by various control points, including technology providers, regulators, and end users. Dependency risks arise from input constraints, such as the availability of critical components, and standards and approvals required for product commercialization. Switching costs and partnerships can also impact the ecosystem, as companies may face significant costs when changing technology providers or integrating new systems. Furthermore, the ecosystem may differ by region due to varying regulatory requirements, market demands, and technology adoption rates.

Recent Industry Insights

The Micro-RNA Sequencing and Assay industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have accelerated innovation, with a notable collaboration between Illumina and Bio-Rad to develop novel micro-RNA sequencing solutions. Additionally, there have been strategic mergers and acquisitions, such as the acquisition of Qiagen by Thermo Fisher Scientific, which has expanded the company's portfolio of micro-RNA sequencing products.

The industry has also seen several product launches, including the introduction of next-generation sequencing platforms and advanced micro-RNA assay kits. Furthermore, regulatory changes, such as the updated guidelines for micro-RNA-based diagnostic tests, have created new opportunities for growth. The shift in consumer trends towards personalized medicine has also driven demand for micro-RNA sequencing and assay services, with several companies securing funding rounds to support the development of novel micro-RNA-based therapies.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Micro-RNA Sequencing and Assay market. The market attractiveness is high due to increasing demand for genetic research and diagnostics. The competitive intensity is moderate, with key players investing in research and development to stay ahead. The long-term outlook for the Micro-RNA Sequencing and Assay market outlook is promising, driven by advancements in technology and growing applications in cancer research.

The innovation landscape is evolving rapidly, with new products and services being launched regularly. However, the demand-supply balance is a key risk factor, as supply chain disruptions can impact market growth. Overall, the market is expected to experience steady growth, but stakeholders must be aware of the potential risks and challenges to make informed decisions.

11 items

1. Executive Summary

2. Micro-RNA Sequencing and Assay Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Micro-RNA Sequencing and Assay Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Micro-RNA Sequencing and Assay Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Sequencing by Synthesis

6.1.2. Sequencing by Nanopore

6.1.3. Ion Semiconductor Sequencing

6.2. Global Micro-RNA Sequencing and Assay Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Research Institute

6.2.2. Academia

6.2.3. CRO

6.3. Global Micro-RNA Sequencing and Assay Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Micro-RNA Sequencing and Assay Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Micro-RNA Sequencing and Assay Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Micro-RNA Sequencing and Assay Market Competition by Key Manufacturers

8.1. Global Micro-RNA Sequencing and Assay Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Micro-RNA Sequencing and Assay: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Illumina

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. QIAGEN

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Takara Bio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. NEB

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Micro-RNA Sequencing and Assay Market

Figure 4: Global Micro-RNA Sequencing and Assay Market: Drivers

Figure 5: Global Micro-RNA Sequencing and Assay Market: Challenges

Figure 6: Global Micro-RNA Sequencing and Assay Market: Trends

Figure 7: Global Micro-RNA Sequencing and Assay Market: Opportunity

Figure 8: Global Micro-RNA Sequencing and Assay Market: Restraint

Figure 9: Global Micro-RNA Sequencing and Assay Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Micro-RNA Sequencing and Assay Market Value (USD Million) By Region

Figure 15: Global Micro-RNA Sequencing and Assay Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Micro-RNA Sequencing and Assay Market Value (USD Million) By Region

Figure 23: Global Micro-RNA Sequencing and Assay Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global Micro-RNA Sequencing and Assay Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Micro-RNA Sequencing and Assay Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Micro-RNA Sequencing and Assay Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Micro-RNA Sequencing and Assay Market Value (USD Million) By Region

Table 10: Global Micro-RNA Sequencing and Assay Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Micro-RNA Sequencing and Assay Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Micro-RNA Sequencing and Assay Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Micro-RNA Sequencing and Assay Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Illumina Basic Information And Sales Area

Table 31: Illumina. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: QIAGEN Basic Information And Sales Area

Table 35: QIAGEN. Products Portfolio

Table 36: Takara Bio Basic Information And Sales Area

Table 37: Takara Bio. Products Portfolio

Table 38: NEB Basic Information And Sales Area

Table 39: NEB. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Type

Table 41: Global Market Share (%) By Type (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Micro-RNA Sequencing and Assay Market Value (USD Million) By Region

Table 45: Global Micro-RNA Sequencing and Assay Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Type

Table 48: North America Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Type

Table 51: Europe Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Type

Table 57: South America Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Micro-RNA Sequencing and Assay Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; QIAGEN; Takara Bio; NEB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options